Trump Tariffs Target Key Ingredients for Dozens of Drugs

Photographer: Dhiraj Singh/Bloomberg

Lock
This article is for subscribers only.

The Trump administration’s proposed tariffs on thousands of Chinese-manufactured products would target dozens of key products used by drugmakers, as well as medical devices including pacemakers and artificial joints.

The 25 percent tariff would be placed on raw ingredients for drugs such as insulin used by diabetics, the anti-allergic-reaction drug epinephrine, as well as vaccines, blood products and antidepressants, according to the list. The tariffs would also target medical devices and diagnostic equipment including syringes, MRI machines, defibrillators, artificial joints, and pacemakers.